Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Treasury Shares (2016 - 2025)

Bio-Techne has reported Treasury Shares over the past 16 years, most recently at $22000.0 for Q2 2025.

  • For Q2 2025, Treasury Shares fell 95.57% year-over-year to $22000.0; the TTM value through Jun 2025 reached $22000.0, down 95.57%, while the annual FY2025 figure was $22000.0, 95.57% down from the prior year.
  • Treasury Shares for Q2 2025 was $22000.0 at Bio-Techne, down from $497000.0 in the prior quarter.
  • Over five years, Treasury Shares peaked at $1.4 million in Q4 2023 and troughed at $22000.0 in Q2 2025.
  • A 5-year average of $312200.0 and a median of $106000.0 in 2021 define the central range for Treasury Shares.
  • Biggest five-year swings in Treasury Shares: skyrocketed 1243.24% in 2024 and later tumbled 95.57% in 2025.
  • Year by year, Treasury Shares stood at $89000.0 in 2021, then surged by 149.44% to $222000.0 in 2022, then skyrocketed by 529.28% to $1.4 million in 2023, then tumbled by 64.42% to $497000.0 in 2024, then tumbled by 95.57% to $22000.0 in 2025.
  • Business Quant data shows Treasury Shares for TECH at $22000.0 in Q2 2025, $497000.0 in Q2 2024, and $1.4 million in Q4 2023.